Why 2025 feels like a fiduciary minefield for benefit managers
Let’s be honest, it feels like our jobs have a target on them right now. If you work in pharma operations, you know exactly what I’m talking about. The spending on GLP-1s is exploding, the PBM contracts feel more confusing than ever, and now we’re seeing lawsuits that name individual executives and committees. It’s getting personal. For benefit managers, the question for 2025 is stark: how do you prove you aren’t overpaying for prescription drugs in your own employee plan, especially when your company might even make some of those drugs? And how do you do all of that without completely burning out your already-swamped team?
The game has changed. Benefit managers have to rethink everything, and the new strategy has to be built on transparency, real value you can actually point to, and documentation that’s ready for an audit at a moment’s notice. And we have to do it fast.
The new fiduciary standard for benefit managers under ERISA
The Johnson & Johnson class-action lawsuit was the moment everyone’s coffee went cold. It sent a clear message to managers worldwide that acting in “good faith” is no more enough. You have to be able show a methodical, analytical way of making sure your employees aren’t being deceived through drug prices. This is especially true when your own organization has a horse in the race, either by manufacturing those drugs or competing with them.
What tighter fiduciary accountability means for benefit managers
Really, three things have become the new baseline for what’s expected of benefit managers when it comes to pharmacy benefits.
Critical safeguards benefit managers must put in place
- Think of this as demanding the right to look under the hood. Benefit managers need contract language that explicitly lets you see the PBM’s math the raw ingredient costs, what they’re paying pharmacies, and where the rebates are going. No more black boxes.
- And speaking of black boxes, spread pricing needs to disappear from your contracts. It’s just the gap between what the PBM bills your plan and what it pays the pharmacy a gap they pocket. Benefit managers have to push for transparent, pass-through models where you pay what they pay.
- This is your paper trail, your “get out of court free” card. Every major decision benefit managers make, from picking a PBM to designing the formulary and setting rules for GLP-1s, must be documented. You need to be able to show *why* you made the choices you did.
- This job isn’t “set it and forget it” anymore. Benefit managers need to be doing regular, almost forensic, reviews of claims data. Are they misclassifying drugs? Are the rebates what they promised? This is now a fundamental part of prudent oversight.
These aren’t just nice ideas or guardrails. For any prudent benefit manager in the pharma world, this is the absolute minimum you should be doing.
Why unbundled and transparent PBMs are becoming non‑negotiable for benefit managers
When the top three PBMs handle something like 80% of all prescription claims, it’s only natural for employers and regulators to start asking if these massive, vertically integrated companies can truly have your best interests at heart. And honestly, that’s why so many benefit managers are now looking at unbundled, pass-through models. It’s like renovating a house: you hire experienced electricians, plumbers, and painters instead of one big firm that does everything. Here, you contract claims processing, clinical management, and rebate negotiations separately. This allows benefit managers to judge each part of the service on its own merits and cost. In these models, every single rebate and fee gets passed through to the plan. No skimming, no fuzzy “admin fees.” The vendors are judged on metrics you can actually see in real-time things like per-member-per-month costs or the trend on your GLP-1 spend. The proof is in the pudding. Benefit managers who have made this switch are seeing spend drop by around 16% without cutting off employee access to meds.
Managing the GLP‑1 cost explosion: where benefit managers are most exposed
OK, let’s address the elephant in the room: GLP-1s. For many of us in pharma, these drugs-Wegovy and Zepbound for obesity and diabetes-are now the single biggest line item in our benefit plans. Global spending was around $47 billion in 2024 and is on track to grow tenfold by 2032. Benefit managers simply can’t just absorb that kind of cost into the plan and hope for the best.
To keep things financially sane and legally defensible, benefit managers are putting some serious controls in place
- This is your first line of defense. We’re talking about tight prior authorizations and step therapy protocols. It’s not about denying care; it’s about ensuring these powerful drugs go to people who meet strict, evidence-based criteria like BMI and comorbidities.
- It’s also completely reasonable to require some shared responsibility. Many are making continued coverage for GLP-1s dependent on the employee actually participating in a nutrition, fitness, or behavioral health program.
- Some plans are getting even more direct by setting annual cost caps or creating a dedicated budget just for GLP-1s. This allows benefit managers to track and control that specific spend without it bleeding into everything else.
- You have to watch the data like a hawk. Benefit managers need monthly reports on who’s starting these drugs, who’s sticking with them, who’s dropping off, and whether they’re actually reducing other medical costs down the line.
The problem, of course, is that all these strategies are incredibly data-heavy and create a ton of administrative work. This is exactly where diligent benefit managers can get overwhelmed and risk letting things slip through the cracks.
Regulatory whiplash: how benefit managers can stay ahead of PBM reforms
Between the FTC’s big report on PBMs in July 2024 and the fact that more than two dozen states passed 33 new PBM laws this year alone, it feels like we’re all getting regulatory whiplash. For benefit managers at multi-state pharma companies, this creates a new reality: you have to build your PBM relationships to meet the strictest rules out there. You can’t have different standards for different states; you have to aim for the highest common denominator or you’ll risk being non-compliant somewhere.
What this means in practice is that benefit managers must keep an eye on state-level bans on things like spread pricing and then apply those changes across the board, not just where it’s legally required. It also means it’s probably wise not to be exclusively dependent on one of the “Big 3” PBMs. Diversifying shows regulators you’re actively encouraging competition. And, tying back to our earlier point, you need to document that you’re actually paying attention to all these changes and adjusting your plan accordingly.
Where benefit managers need operational backup not more theory
Most benefit managers in pharma aren’t in the dark about what needs to be done. We’ve all read the articles. We need more audits, more transparency, and tighter controls on GLP-1s. In theory, we know what we need. The real problem is finding the time and people to actually do the work: reviewing those thousands of claims, validating those PBM reports, keeping that meticulous documentation trail; it’s a big ongoing, highly manual job piled on top of an already full plate.
This is where getting some specialized operational support stops being a simple cost-saving measure and starts becoming a strategic necessity for benefit managers.
How Bot Medics Care strengthens benefit managers in pharmaceutical operations
Think of Bot Medics Care (BMC) as the operational extension of your own benefits team. We provide benefit managers with the bandwidth, the processes, and the clean data you need to navigate this fiduciary minefield without having to hire a whole new department.
High‑impact support areas for benefit managers
- Data accuracy & claims-related back office: BMC’s healthcare back-office solutions for benefit managers handle the thankless work of eligibility management, data entry, and reconciliation. The result is that your PBM reports and internal numbers are finally clean and trustworthy for an audit.
- Employee communication & change management: With our healthcare-specialized customer care, BMC can field all the inbound calls and questions about new GLP-1 rules or UM requirements. This frees up benefit managers and your HR team from a ton of noise.
- Campaigns that drive smarter utilization: Using outbound, email, and SMS campaigns, BMC helps benefit managers actively guide employees toward more cost-effective choices, like preferred pharmacies or adherence programs, which helps control costs and improve outcomes.
- Administrative muscle for UM and documentation: BMC’s data entry and administrative support provides the horsepower to implement and maintain prior authorizations for GLP-1s, track who is participating in lifestyle programs, and build that crucial documentation trail benefit managers need for ERISA compliance.
- Custom tools for benefit managers: For pharma companies that need a clearer view, BMC’s healthcare software development team can build simple dashboards and tools. These let you track PBM performance, GLP-1 spend, and other key metrics without digging through a hundred spreadsheets.
Because BMC works exclusively in healthcare with clients across the UK, Switzerland, Israel, Italy, Northern Europe, and the USA including providers and ePharmacies our teams just get it. We understand the specific regulatory and operational headaches benefit managers are dealing with every single day.
Benefit managers are facing an important period of time in the next twelve to twenty-four months.
These next twelve to twenty-four months will determine if the organization is going to be viewed as a transparent and prudently managed organization or if it is going to be a potential target for lawsuits and regulatory scrutiny. Benefit managers do not need another guidebook full of information on how to do your job. They need an organization that they can trust to provide the ability to implement and document their organizational objectives.
If you’re ready to de-risk your pharmacy benefits, get a clear line of sight into your costs, and support your employees without overwhelming your staff, it’s time to explore how botmedicscare.com can support benefit managers with specialized healthcare BPO services tailored to pharmaceutical operations.